Pfizer reshuffles top ranks with Albert Bourla as COO; Intra-cellular nabs Novartis vet Andrew Satlin as CMO
→ Pfizer has promoted its Innovative Health chief Albert Bourla to the new role of chief operating officer, where he’s been given a special mandate to oversee the day-to-day activity around product development, sales and strategy. This has been interpreted as CEO Ian Read’s way of anointing his successor, although that is far from certain. The move, which becomes official on January 1, triggered a reshuffle in the top ranks at Pfizer. John Young, who heads Pfizer Essential Health, takes Bourla’s old job, while Angela Hwang succeeds Young.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.